未知生产厂商
AZD-9684 is the first member of a new anti-thrombotic class (CPU inhibitors). It is being developed by AstraZeneca.
AZD-9684 is the first member of a new anti-thrombotic class (CPU inhibitors). It is being developed by AstraZeneca.
AZD-9684 is a Carboxypeptidase U inhibitor (CPUi).
Investigated for use/treatment in thrombosis.
